ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

NIH Funding Opportunities Listed

March 13, 2009

Letter: Headline Criticized On Letter About Consortium

June 21, 1996

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

Cancer Cases To Double By 2050 As U.S. Population Ages, Annual Report Says.

May 17, 2002

DCE Board Approves Concept For studies Of Thorotrast Exposure

November 16, 1990

ASCO Annual Meeting Abstracts Posted Online

May 28, 2010